Alitretinoin, or 9-cis-retinoic acid, is a form of
vitamin A. It is also used in medicine as an
antineoplastic (anti-cancer) agent developed by Ligand Pharmaceuticals. It is a first generation
retinoid. Ligand gained
Food and Drug Administration (FDA) approval for alitretinoin in February 1999.